Predicting stereotactic radiosurgery outcomes with multi-observer qualitative appearance labelling versus MRI radiomics.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
received:
10
05
2023
accepted:
17
11
2023
medline:
30
11
2023
pubmed:
29
11
2023
entrez:
28
11
2023
Statut:
epublish
Résumé
Qualitative observer-based and quantitative radiomics-based analyses of T1w contrast-enhanced magnetic resonance imaging (T1w-CE MRI) have both been shown to predict the outcomes of brain metastasis (BM) stereotactic radiosurgery (SRS). Comparison of these methods and interpretation of radiomics-based machine learning (ML) models remains limited. To address this need, we collected a dataset of n = 123 BMs from 99 patients including 12 clinical features, 107 pre-treatment T1w-CE MRI radiomic features, and BM post-SRS progression scores. A previously published outcome model using SRS dose prescription and five-way BM qualitative appearance scoring was evaluated. We found high qualitative scoring interobserver variability across five observers that negatively impacted the model's risk stratification. Radiomics-based ML models trained to replicate the qualitative scoring did so with high accuracy (bootstrap-corrected AUC = 0.84-0.94), but risk stratification using these replicated qualitative scores remained poor. Radiomics-based ML models trained to directly predict post-SRS progression offered enhanced risk stratification (Kaplan-Meier rank-sum p = 0.0003) compared to using qualitative appearance. The qualitative appearance scoring enabled interpretation of the progression radiomics-based ML model, with necrotic BMs and a subset of heterogeneous BMs predicted as being at high-risk of post-SRS progression, in agreement with current radiobiological understanding. Our study's results show that while radiomics-based SRS outcome models out-perform qualitative appearance analysis, qualitative appearance still provides critical insight into ML model operation.
Identifiants
pubmed: 38017055
doi: 10.1038/s41598-023-47702-8
pii: 10.1038/s41598-023-47702-8
pmc: PMC10684869
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20977Informations de copyright
© 2023. The Author(s).
Références
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):996-1001
pubmed: 19783374
J Clin Oncol. 2020 Nov 10;38(32):3773-3784
pubmed: 32931399
Oncologist. 2013;18(3):330-5
pubmed: 23429647
Med Phys. 2021 Sep;48(9):5522-5530
pubmed: 34287940
Radiother Oncol. 2022 Jan;166:37-43
pubmed: 34801629
Sci Rep. 2022 Dec 5;12(1):20975
pubmed: 36471160
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Sci Rep. 2019 Dec 27;9(1):19830
pubmed: 31882597
Neuro Oncol. 2020 Jun 9;22(6):797-805
pubmed: 31956919
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):25-30
pubmed: 9300736
Cancers (Basel). 2021 Aug 10;13(16):
pubmed: 34439186
Radiology. 1999 Jun;211(3):807-14
pubmed: 10352610
Med Phys. 2022 Nov;49(11):7167-7178
pubmed: 35727568
Radiat Med. 1999 Jul-Aug;17(4):311-5
pubmed: 10510905
J Neurosurg. 2015 Aug;123(2):373-86
pubmed: 25978710
Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):375-83
pubmed: 9069310
Neurosurgery. 2018 Sep 1;83(3):345-353
pubmed: 29126142
J Clin Oncol. 2022 Feb 10;40(5):492-516
pubmed: 34932393
Radiother Oncol. 2023 Jan;178:109424
pubmed: 36435336
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Front Oncol. 2021 Jan 11;10:569461
pubmed: 33505904
Sci Rep. 2021 Nov 3;11(1):21620
pubmed: 34732781
Magn Reson Imaging. 2004 Jan;22(1):81-91
pubmed: 14972397
Front Oncol. 2023 Mar 13;13:1114194
pubmed: 36994193
Ann Oncol. 2021 Nov;32(11):1332-1347
pubmed: 34364998
Eur Radiol. 2022 Apr;32(4):2266-2276
pubmed: 34978579
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
Cancer. 1997 Dec 1;80(11):2075-83
pubmed: 9392329
Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):139-46
pubmed: 11316557
Clin Transl Radiat Oncol. 2021 May 08;29:27-32
pubmed: 34095557
IEEE J Transl Eng Health Med. 2022 Nov 04;11:13-22
pubmed: 36478770
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
Nat Rev Clin Oncol. 2012 Dec;9(12):674-87
pubmed: 23149893